Document is current
Any future updates will be listed below
-
Authors
Robinson, Sandra M. https://orcid.org/0000-0001-9960-8769
Scott, Jason
Ryan, Sarah
Adams, Nicola
Hassell, Andrew
Walker, David
-
Funding
Funding for this research was provided by:
Roche (20166)
- License Information
-
More Information
Article History
Received: 5 July 2022
Revised: 5 July 2022
Accepted: 10 August 2022
First Online: 18 August 2022
Declarations
:
: Ethical approval was granted by NRES Committee North East – Sunderland.
: Dr David Walker has undertaken advisory boards and speaker meetings for Gilead Sciences Ltd, Ely Lily Pharmaceuticals, Janssen and Janssen Pharmaceuticals, Pfizer Pharmaceuticals and Galapagos. Dr Sandra M Robinson has no conflict of interest. Prof Jason Scott has no conflict of interest. Prof Sarah Ryan has no conflict of interest. Prof Nicola Adams has no conflict of interest. Prof Andrew Hassell has no conflict of interest.
